Rbf Capital »

Contineum Therapeutics shares owned by Rbf Capital

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Rbf Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $470k 40k 11.75
2025-06-30 $159k 40k 3.97

More positions owned by Rbf Capital

Morgan Stanley Com New Put Option (MS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Applovin Corp Com Cl A (APP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Bank of America Corporation (BAC)
Danaos Corporation SHS (DAC)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Visa Com Cl A (V)
Hca Holdings (HCA)
Builders FirstSource (BLDR)
Apple (AAPL)
Fair Isaac Corporation (FICO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Rbf Capital

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics